Breaking News

HHS terminates NIH program for diversifying biomedical workforce

August 26, 2025
Adobe

HHS terminates NIH program aimed at diversifying biomedical workforce

Grant applications for the program, seen at odds with President Trump's ban on DEI efforts, had previously fallen out of favor.

By Veronica Paulus


STAT+ | Eli Lilly's obesity pill helped lower weight, blood sugar in key Phase 3 trial

Lilly to file for regulatory approval for daily weight loss pill after GLP-1 drug orforglipron leads to 9.6% loss in body weight and lower blood sugar.

By Elaine Chen


STAT+ | Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty

CEO Jacob Thaysen tells STAT how Illumina plans to grow amid tariffs and NIH funding battles — while betting big on multiomics

By Jonathan Wosen



Adobe

Opinion: Hospice was meant to offer dignity in death — but it fails the most marginalized

Hospice, like all health care, is supposed to adapt to the patient. Too often, it's the patient who is forced to adapt — or be left out entirely.

By Christopher M. Smith


STAT+ | Akeso says its closely watched drug improved patient survival in a lung cancer trial

Seen as a rival to Keytruda, the Chinese biotech's ivonescimab has quickly become one of the most closely watched drugs in oncology

By Jonathan Wosen


Opinion: We surveyed hundreds of biomedical researchers about the instability in federal funding. Here's what they said

We surveyed hundreds of biomedical researchers about how they are affected by instability in federal funding. They are devastated.

By Arghavan Salles, Tiffany Do, and Emily Mastej


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments